ANGUS Chemical Company announced plans to expand U.S. production capacity for its complete portfolio of TRIS AMINO™ tromethamine buffers. ANGUS is the world's largest and only fully integrated original manufacturer of TRIS AMINO buffers, which are used extensively in bioprocessing and diagnostics manufacturing, as building blocks for synthesis of surface-active agents and pharmaceuticals, and emulsifying agents for cosmetic creams and lotions, among others.
The planned expansion includes the addition of a fourth dedicated manufacturing line at ANGUS' existing facility in Sterlington, Louisiana, and will roughly double the Company's global TRIS AMINO buffer production capacity. Today, the company produces high-purity, multi-compendial grades of TRIS AMINO products for the life sciences and personal care markets at its Sterlington and recently expanded Ibbenbüren, Germany manufacturing facilities.
"This is a significant investment that highlights our commitment to continuously expanding our asset base and global manufacturing capabilities to support fast-growing demand for TRIS AMINO buffers across life sciences, personal care and industrial markets," said David Neuberger, ANGUS President and Chief Executive Officer. "It not only supports the pursuit of our vision to position ANGUS as a leading global supplier of essential life sciences ingredients, but also further enhances the supply chain continuity and security of supply we provide to our customers for this essential chemistry."
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!